CAS No. |
37905-08-1 |
中文名称 |
(4aR,6aS,7aR,10aR,11aR,11bR,11cR)-4,4,8,11c-四甲基-1,2,3,4,4a,5,6,11a,11b,11c-十氢-双(氧杂环丙烯并)[2',3':1,10a;2'',3'':3,4]菲并[3,2-b]呋喃-9(7aH)-酮 |
英文名称 |
(4aR,6aS,7aR,10aR,11aR,11bR,11cR)-4,4,8,11c-tetramethyl-1,2,3,4,4a,5,6,11a,11b,11c-decahydrobis(oxireno)[2',3':1,10a;2'',3'':3,4]phenanthro[3,2-b]furan-9(7aH)-one |
别名 |
jolkinolide B;(4aR,6aS,7aβ,10aR)-1,2,3,4,4aα,5,6,11aβ,11bα,11c-Decahydro-4,4,8,11cβ-tetramethylbisoxireno[1,10a:3,4]phenanthro[3,2-b]furan-9(7aH)-one;1,4-dibutyl-N-(2,6-dimethylphenyl)piperazine-2-carboxamide,nitrous acid;Bisoxireno[1,10a:3,4]phenanthro[3,2-b]furan-9(7aH)-one, 1,2,3,4,4a,5,6,11a,11b,11c-decahydro-4,4,8,11c-tetramethyl-, (4aR,6aS,7aR,10aR,11aR,11bR,11cR)-;(4aR,6aS,7aR,10aR,11aR,11bR,11cR)-4,4,8,11c-tetramethyl-1,2,...;Ritacin P;Ritacin-P;Jolkinolide B, 10 mM in DMSO |
标准英文名 |
(4aR,6aS,7aR,10aR,11aR,11bR,11cR)-4,4,8,11c-tetramethyl-1,2,3,4,4a,5,6,11a,11b,11c-decahydrobis(oxireno)[2',3':1,10a;2'',3'':3,4]phenanthro[3,2-b]furan-9(7aH)-one |
MDL No. |
MFCD28387432 |
分子式 |
C20H26O4 |
分子量 |
330.42
|
精确分子量 |
330.18
|
SMILES |
CC1=C2[C@H]3O[C@]34CC[C@@H]3C(C)(C)CCC[C@@]3(C)[C@@H]4[C@H]3O[C@@]23OC1=O |
标准SMILES |
CC1(C)CCC[C@]2(C)[C@@H]1CC[C@@]13O[C@@H]1C1=C(C)C(=O)O[C@@]41O[C@@H]4[C@@H]23 |
用途 |
Jolkinolide B exhibits anti-tumor activity and can be used for the treatment of malignant tumors; it significantly inhibits the proliferation of human breast cancer MDA-MB-231 cells and induces G1 cell cycle arrest, potentially through downregulation of eIF4E and CyclinD1 expression; it also suppresses the growth of human ovarian cancer SKOV3 cells and promotes apoptosis, possibly by inhibiting the PI3K/Akt signaling pathway and inducing death receptor expression; additionally, it demonstrates notable anti-inflammatory effects. |
InChIKey |
SOVOCMGDFRGRKF-MCDHERAVSA-N |